Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus
- PMID: 20662065
- PMCID: PMC3593718
- DOI: 10.1002/art.27658
Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus
Abstract
Objective: Cardiac manifestations of neonatal lupus, comprising atrioventricular conduction defects and cardiomyopathy, occur in fetuses exposed to anti-Ro/SSA antibodies, and carry substantial mortality. There is strong evidence of a genetic contribution to the risk. This study was undertaken to evaluate single-nucleotide polymorphisms (SNPs) for associations with cardiac neonatal lupus.
Methods: Children of European ancestry with cardiac neonatal lupus (n = 116) were genotyped using the Illumina 370K SNP platform and merged with 3,351 controls. Odds ratios (ORs) and 95% confidence intervals (95% CIs) for association with cardiac neonatal lupus were determined.
Results: The 17 most significant associations with cardiac neonatal lupus were found in the HLA region. The region near the MICB gene showed the strongest variant (rs3099844; P(dom) = 4.52 × 10(-10) , OR 3.34 [95% CI 2.29-4.89]), followed by a missense variant within C6orf10 (rs7775397; P(dom) = 1.35 × 10(-9) , OR 3.30), which lies between NOTCH4 and BTNL2, and several SNPs near the tumor necrosis factor α gene, including rs2857595 (P(add) = 1.96 × 10(-9) , OR 2.37), rs2230365 (P(add) = 1.00 × 10(-3) , OR 0.46), and rs3128982 (P(add) = 6.40 × 10(-6) , OR 1.86). Outside the HLA region, an association was detected at 21q22, upstream of the transcription regulator ets-related isoform 1 (rs743446; P = 5.45 × 10(-6) , OR 2.40). HLA notwithstanding, no individual locus previously implicated in autoimmune diseases achieved genome-wide significance.
Conclusion: These results suggest that variation near genes related to inflammatory and apoptotic responses may promote cardiac injury initiated by passively acquired autoantibodies.
Copyright © 2010 by the American College of Rheumatology.
Figures
References
-
- Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM, Jr, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med. 1977;297:1204–1207. - PubMed
-
- Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983;309:209–212. - PubMed
-
- Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, et al. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr. 1983;103:889–891. - PubMed
-
- Buyon J, Roubey R, Swersky S, Pompeo L, Parke A, Baxi L, et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol. 1988;15:1104–1108. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AR042455/AR/NIAMS NIH HHS/United States
- P20-RR-020143-06/RR/NCRR NIH HHS/United States
- N01-AR-62277/AR/NIAMS NIH HHS/United States
- R37-AI-024717-21/AI/NIAID NIH HHS/United States
- N01 AR062277/AR/NIAMS NIH HHS/United States
- N01 AR042271/AR/NIAMS NIH HHS/United States
- R01-DE-018209-01A1/DE/NIDCR NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- P01-AI-083194-01/AI/NIAID NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- R01 DE018209/DE/NIDCR NIH HHS/United States
- AR-42455/AR/NIAMS NIH HHS/United States
- P20 RR020143/RR/NCRR NIH HHS/United States
- U19 AI082714/AI/NIAID NIH HHS/United States
- P30 GM103510/GM/NIGMS NIH HHS/United States
- R37 AR042455/AR/NIAMS NIH HHS/United States
- P01-AR-049084-07/AR/NIAMS NIH HHS/United States
- R01-AR-042460-15/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- N01 AR042220/AR/NIAMS NIH HHS/United States
- U19-AI-082714-01/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
